CONCENTRATIONS	6 Months Ended
Jun. 30, 2022
CONCENTRATIONS
CONCENTRATIONS	(14) CONCENTRATIONS For the three months ended June 30, 2022, the Company sourced approximately 58% of the supplies for its electrotherapy products from four significant vendors. For the same period in 2021, the Company sourced approximately 31% of the supplies for its electrotherapy products from one significant vendor. For the six months ended June 30, 2022, the Company sourced approximately 53% of supplies for its electrotherapy products from four significant vendors. For the same period in 2021, the Company sourced approximately 35% of supplies for its electrotherapy products from two significant vendors. Management believes that its relationships with suppliers are good; however, if the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred. At June 30, 2022, the Company had receivables from one third-party payer that made up approximately 18% of the net accounts receivable balance. At December 31, 2021, the Company had receivables from one third-party payer which made up approximately 22% of the net accounts receivable balance.

CONCENTRATIONS

6 Months Ended

Jun. 30, 2022

(14) CONCENTRATIONS

For the three months ended June 30, 2022, the Company sourced approximately 58% of the supplies for its electrotherapy products from four significant vendors. For the same period in 2021, the Company sourced approximately 31% of the supplies for its electrotherapy products from one significant vendor.

For the six months ended June 30, 2022, the Company sourced approximately 53% of supplies for its electrotherapy products from four significant vendors. For the same period in 2021, the Company sourced approximately 35% of supplies for its electrotherapy products from two significant vendors.

Management believes that its relationships with suppliers are good; however, if the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred.

At June 30, 2022, the Company had receivables from one third-party payer that made up approximately 18% of the net accounts receivable balance. At December 31, 2021, the Company had receivables from one third-party payer which made up approximately 22% of the net accounts receivable balance.